Surims Ltd Logo
Progenity Logo  
Basic Profile
If you'd like to claim this company profile for Progenity, please Contact Us.

Progenity News

The latest news, announcements and press releases from Progenity.

13th April 2021

Progenity and Ionis Pharmaceuticals Enter into Agreement

SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, today announced an agreement with Ionis Pharmaceuticals, the leader in RNA-targeted therapeutics, to evaluate the safety, tolerability and performance of Progenity’s Oral Biotherapeutics Delivery System (OBDS) for oral systemic delivery of antisense oligonucleotides, developed and manufactured by Ionis.

Ionis’ novel antisense therapies are designed to target mRNA in a highly specific manner, so that the amount of disease-causing protein is dramatically decreased. Antisense therapies can also treat diseases caused by too little protein by increasing the production of the protein, thereby restoring the protein to normal levels.

Read the full story »

Claim This Profile

This is the News section of the company profile page for Progenity on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

Progenity company details, activities, contacts and reviews.
Progenity partnership and licensing opportunities.
Progenity latest news, announcements and press releases.
Progenity documents, images and videos.
Progenity global factories, offices and locations.
Progenity legal and financial information.

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at


Get in Touch

The Pharmaceutical Services Directory


© 2021 Surims Ltd | All Rights Reserved.